[1]
Rakhmatov, O. 2023. EVALUATION OF CHANGES IN INTERLEUKIN-4 LEVELS WHEN USING THE IMMUNOMODULATOR GEPON IN THE TREATMENT OF PATIENTS WITH CUTANEOUS LEISHMANIASIS. RESEARCH AND EDUCATION. 2, 5 (May 2023), 269–278.